Sep 1, 2026 07:15AM
Jan 30, 2026 06:47AM
Jul 1, 2025 06:47AM
Jun 3, 2025 06:44AM
Apr 11, 2025 06:37AM
Mar 10, 2025 06:47AM
Mar 4, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Feb 24, 2025 07:10AM
Nov 19, 2024 06:55AM
Sep 12, 2024 07:29AM
Sep 3, 2024 07:30AM
Aug 7, 2024 06:49AM
Jun 17, 2024 06:43AM
Sep 5, 2023 07:30AM Protagonist Therapeutics to Present at Upcoming Investor Conferences
Apr 4, 2023 10:45PM
Apr 4, 2023 04:12PM
Apr 4, 2023 04:11PM
Jan 4, 2022 07:00AM
Jan 4, 2022 07:00AM
Jun 21, 2021 07:30AM
Jun 18, 2021 04:05PM Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jun 16, 2021 06:18AM
Jun 15, 2021 09:07PM
Jun 14, 2021 05:01PM
Jun 14, 2021 05:00PM
Mar 23, 2021 09:28AM
Mar 2, 2021 07:00AM
Sep 10, 2020 04:30PM Protagonist Therapeutics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
May 18, 2020 07:50AM
May 12, 2020 12:57AM
May 11, 2020 07:00AM
May 11, 2020 06:59AM
Sep 3, 2019 04:30PM
Jul 8, 2019 07:13AM
Apr 1, 2019 07:00AM Protagonist Therapeutics to Present at the H.C. Wainwright & Co. Global Life Sciences Conference on Tuesday, April 9
Mar 26, 2018 09:13AM

22,067 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All